Literature DB >> 3266767

Urine human epidermal growth factor (hEGF) levels following surgery.

Y Abe1, M Miyake, T Sagawa, S Kimura.   

Abstract

In order to investigate the contribution of growth factors in conditions of postoperative stress, we measured the blood and urine hEGF levels in patients with various surgical disorders. While the levels of serum and plasma hEGF did not change significantly after surgery, urine hEGF (u-hEGF) stayed at the base-level followed by a single peak within a postoperative period of two weeks. The peak day of u-hEGF in patients with more than 1000 ml of intraoperative bleeding was later than that in patients with bleeding of less than 1000 ml. In patients with postoperative renal failure or dysfunction, u-hEGF levels dropped and did not rise until the recovery of renal function. The changing pattern of u-hEGF levels was an indicator of operative bleeding volume and renal function.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3266767     DOI: 10.1007/bf02471524

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  15 in total

1.  Radioimmunoassay of human epidermal growth factor (urogastrone).

Authors:  R H Starkey; D N Orth
Journal:  J Clin Endocrinol Metab       Date:  1977-12       Impact factor: 5.958

2.  Immunocytochemical localization of epidermal growth factor in mouse kidney.

Authors:  E C Salido; L Barajas; J Lechago; N P Laborde; D A Fisher
Journal:  J Histochem Cytochem       Date:  1986-09       Impact factor: 2.479

Review 3.  Epidermal growth factor-urogastrone, a polypeptide acquiring hormonal status.

Authors:  M D Hollenberg
Journal:  Vitam Horm       Date:  1979       Impact factor: 3.421

Review 4.  Interleukin-1 and the pathogenesis of the acute-phase response.

Authors:  C A Dinarello
Journal:  N Engl J Med       Date:  1984-11-29       Impact factor: 91.245

5.  Do operations facilitate tumor growth? An experimental model in rats.

Authors:  J L Weese; F D Ottery; S E Emoto
Journal:  Surgery       Date:  1986-08       Impact factor: 3.982

6.  Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets.

Authors:  Y Oka; D N Orth
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

7.  Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues.

Authors:  L B Rall; J Scott; G I Bell; R J Crawford; J D Penschow; H D Niall; J P Coghlan
Journal:  Nature       Date:  1985 Jan 17-23       Impact factor: 49.962

8.  Enzyme-linked immunosorbent assay (ELISA) for human epidermal growth factor (hEGF).

Authors:  Y Abe; T Sagawa; K Sakai; S Kimura
Journal:  Clin Chim Acta       Date:  1987-09-15       Impact factor: 3.786

9.  Laparotomy enhances intraperitoneal tumor growth and abrogates the antitumor effects of interleukin-2 and lymphokine-activated killer cells.

Authors:  A M Eggermont; E P Steller; P H Sugarbaker
Journal:  Surgery       Date:  1987-07       Impact factor: 3.982

10.  Subnormal concentrations of urinary epidermal growth factor in patients with kidney disease.

Authors:  A L Mattila; A Pasternack; L Viinikka; J Perheentupa
Journal:  J Clin Endocrinol Metab       Date:  1986-06       Impact factor: 5.958

View more
  1 in total

1.  Decreased urinary epidermal growth factor levels in diabetic patients.

Authors:  Y Abe; M Miyake; A Horiuchi; S Kimura
Journal:  Jpn J Surg       Date:  1991-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.